MedPath

Application of Functional Renal MRI to Improve Assessment of Chronic Kidney Disease

Recruiting
Conditions
Chronic Kidney Diseases
Interventions
Diagnostic Test: Multiparametric renal MRI
Registration Number
NCT04238299
Lead Sponsor
University Hospitals of Derby and Burton NHS Foundation Trust
Brief Summary

Research question: Can multiparametric renal Magnetic Resonance Imaging (MRI) provide structural and functional assessment of the kidneys to deliver prognostic information and guide treatment options in chronic kidney disease (CKD)?

Aims and objectives:

1. To establish a multiparametric renal MRI protocol in CKD cohorts.

2. To use multiparametric MRI to characterise people with and without CKD progression.

3. To compare multiparametric renal MRI with 'gold-standard' renal biopsy to determine pathological processes of CKD progression that are detectable by MRI.

Detailed Description

The study will have three stages.

Stage 1: 45 people with CKD from nine UKRIN centres will undergo multiparametric MRI to test patient tolerance, data completeness and central data collection processes.

Stage 2: A multicentre, prospective cohort study of 450 people with CKD, collecting multiparametric renal MRI at baseline and 2 years. Long-term outcomes will be determined with efficient tracking of kidney failure events via the UK Renal Registry at 5 and 10 years.

Stage 3: A mechanistic sub-study of 45 patients (from Stage 2) who have had a routine renal biopsy. Detailed comparisons will be made between multiparametric MRI and histopathological changes. Tissue blocks will undergo quantitative analysis of fibrosis, capillary density and inflammation using immunohistochemistry techniques.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
450
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Main study cohortMultiparametric renal MRIPatients with CKD recruited from specialist nephrology clinics
Primary Outcome Measures
NameTimeMethod
CKD progression10 years

kidney failure (doubling of serum creatinine, eGFR\<15ml/min or RRT) OR a 40% decline in eGFR

Secondary Outcome Measures
NameTimeMethod
Kidney failure events10 years

Doubling of serum creatinine, eGFR\<15ml/min or RRT

40% decline in eGFR from baseline10 years
AKI events4 years

AKI as per KDIGO serum creatinine criteria

eGFR trajectory2 years

(ml/min/yr)

Cardiovascular events4 years
All cause mortality10 years

Trial Locations

Locations (1)

Royal Derby Hospital

🇬🇧

Derby, Derbyshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath